Remedium Bio

Remedium Bio, founded in 2020, is a pioneering startup in the Biotechnology and Health Care sectors, headquartered in the United States. The company's motto, "We believe that any disease can be cured", underlines its ambitious mission.

Remedium Bio has developed the revolutionary Prometheus™ adjustable gene therapy platform, which offers a groundbreaking solution to replace traditional multi-injection subcutaneous biologics with a single treatment. This platform is noted for delivering therapeutic genes safely, effectively, and durably without genetic integration, significantly reducing costs.

The company’s lead product targets Osteoarthritis, leveraging the only clinically validated chondro-regenerative mechanism. Further, their pipeline includes potential treatments for Weight Loss, Type 2 Diabetes, and Stroke.

Remedium Bio's recent financial backing came from a grant investment by the National Science Foundation on 01 August 2023, reflecting confidence in the company's innovative approach to addressing large unmet clinical needs.